Observations, predictions and decisions - Assessing cardiovascular risk assessment

International Journal of Epidemiology

Volumn 33, Issue 2, 2004, Pages 235-239

  Hense, Hans Werner ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; EDITORIAL; ELECTROCARDIOGRAPHY; ETHNOLOGY; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; VALIDATION PROCESS;

CARDIOVASCULAR DISEASES; EPIDEMIOLOGIC METHODS; HUMANS; RISK ASSESSMENT;

EID: 2342516164     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyh118     Document Type: Editorial

References (38)

1. Rose G. Environmental health: problems and prospects. J R Coll Physicians Lond 1991;25:48-52.
2. Expert Panel on Detection EaToHBCiAAI. Executive Summary of the 3rd Report of the National Cholesterol Education program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III). JAMA 2001;285:2486-97.
3. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10.
4. Chobanian A, Bakris GL, Black HR et al. The 7th Report of the Joint National Committee on Detection, Prevention, Evaluation and Treatment of High Blood Pressure. JAMA 2003;289:2560-72.
5. Ramsay LE, Williams B, Johnston GD et al. British hypertension society guidelines for hypertension management 1999: summary. BMJ 1999;319:630-35.
6. AHA Committee on Reduction of Risk of Heart Attack and Stroke. American Heart Association Coronary Risk Handbook. 1973.
7. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-98.
8. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
9. Sackett D, Haynes R, Guyatt G, Tugwell P. Clinical Epidemiology, 2nd Edn. Boston, Toronto, London: Little, Brown and Company, 1991.
10. Jackson R, Barham P, Bills J et al. Management of raised blood pressure in New Zealand: a discussion document. BMJ 1993;307:107-10.
11. Wilson P, D'Agostino R, Levy D, Belanger A, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
12. Thomsen TF, Davidsen M, Ibsen H, Jorgensen T, Jensen G, Borch-Johnsen K. A new method for CHD prediction and prevention based on regional risk scores and randomized clinical trials. J Cardiovasc Risk 2001;8:291-97.
13. Thomsen TF, McGee DM, Davidsen M, Jorgensen T. A cross-validation of risk scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study. Int J Epidemiol 2002;31:817-22.
14. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Münster (PROCAM) Study. Circulation 2002;105:310-15.
15. Conroy RM, Pyorala K, Fitzgerald AP et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003.
16. Voss R, Cullen P. Schulte H, Assmann G. Prediction of risk of coronary events in middle-aged men in the Prospective Cardiovascular Münster Study (PROCAM) using neural networks. Int J Epidemiol 2002;31:1253-62.
17. WHO MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates and case fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583-612.
18. Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000;21:365-70.
19. Marrugat J, D'Agostino R, Sullivan L et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health 2003;57:634-38.
20. Laurier D, Nguyen PC, Cazelles B, Segond P. Estimation of CHD risk in a French working population using a modified Framingham model. The PCV-METRA Group. J Clin Epidemiol 1994;47:1353-64.
21. Brindle P, Emberson J, Lampe F et al. The Framingham score overestimates coronary risk in British men. A prospective study. BMJ 2003;327:1267-73.
22. Hense HW, Schulte H, Lowel H, Assmann G, Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany - results from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J 2003;24:937-45.
23. Empana JP, Ducimetiere P. Arveiler D et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations. Eur Heart J 2003;24:1903-11.
24. D'Agostino RB, Grundy S, Sullivan L.M., Wilson PW. Validation of the Framingham coronary heart disease prediction scores. Results front a multiple ethnic groups investigation. JAMA 2001; 286:180-87.
25. Milne R, Gamble G, Whitlock G, Jackson PR. Framingham Heart Study risk equation predicts first cardiovascular event rates in New Zealanders at the population level. N Z Med J 2003;116: U662.
26. Stewart AW, Kuulasmaa K, Beaglehole R, for the WHO MONICA Project. Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. Int J Epidemiol 1994;23:505-16.
27. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M et al. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999;353:1547-57.
28. Kuulasmaa K, Tunstall-Pedoe H, Dobson A et al. Estimation of contribution of changes in classic risk factors to trends in coronary event rates across the WHO MONICA Project populations. Lancet 2000;355:675-87.
29. Verschuren WM, Jacobs DR, Bloemberg BP et al. Serum total cholesterol and long-term coronary heart disease mortality in different countries. Twenty-five-year follow-up of the Seven Countries Study. JAMA 1995;274:131-36.
30. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kuulasmaa K. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. New Engl J Med 2000;342:1-8.
31. Chambless L, Folsom A, Sharrett A et al. Coronary heart disease risk prediction in the ARIC study. J Clin Epidemiol 2003;56:880-90.
32. Clarke R, Shipley M, Lewington S et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999;150:341-53.
33. Hennekens CH, D'Agostino RB. Global risk assessment for cardiovascular disease and astute clinical judgement. Eur Heart J 2003;24:1899-900.
34. Benichou J. Absolute risk. In: Gail MH, Benicou J (eds). Encyclopedia of Epidemiologic Methods. Chichester: Wiley & Sons, 2000, pp. 1-17.
35. Milne R, Gamble G, Whitlock G, Jackson PR. Discriminative ability of a risk-prediction tool derived from the Framingham Heart Study compared with single risk factors. N Z Med J 2003;116:U663.
36. May M. Commentary: Improved coronary risk prediction using neural networks. Int J Epidemiol 2002;31:1262-64.
37. Hense HW. Risk factor scoring for coronary heart disease. Prediction algorithms need regular updating. BMJ 2003;327:1238-39.
38. Jackson R. Updated New Zealand cardiovascular disease risk-benefit prediction guide. BMJ 2000;320:709-10.